Barclays’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.03M | Sell |
|
|||||
|
2025
Q1 | $11.6M | Buy |
|
|||||
|
2024
Q4 | $1.11M | Sell |
|
|||||
|
2024
Q3 | $2.43M | Buy |
|
|||||
|
2024
Q2 | $1.51M | Buy |
|
|||||
|
2024
Q1 | $1.59M | Buy |
|
|||||
|
2023
Q4 | $102K | Sell |
|
|||||
|
2023
Q3 | $148K | Sell |
|
|||||
|
2023
Q2 | $184K | Buy |
|
|||||
|
2023
Q1 | $19K | Sell |
|
|||||
|
2022
Q4 | $660K | Sell |
|
|||||
|
2022
Q3 | $5.49M | Sell |
|
|||||
|
2022
Q2 | $11M | Sell |
|
|||||
|
2022
Q1 | $13.6M | Buy |
|
|||||
|
2021
Q4 | $10.9M | Buy |
|
|||||
|
2021
Q3 | $13.8M | Buy |
|
|||||
|
2021
Q2 | $11.3M | Buy |
|
|||||
|
2021
Q1 | $9.64M | Sell |
|
|||||
|
2020
Q4 | $19.7M | Buy |
|
|||||
|
2020
Q3 | $18.8M | Sell |
|
|||||
|
2020
Q2 | $12.6M | Sell |
|
|||||
|
2020
Q1 | $11.4M | Buy |
|
|||||
|
2019
Q4 | $12.3M | Buy |
|
|||||
|
2019
Q3 | $7.86M | Sell |
|
|||||
|
2019
Q2 | $8.27M | Buy |
|
|||||
|
2019
Q1 | $269K | Sell |
|
|||||
|
2018
Q4 | $1.44M | Buy |
|
|||||
|
2018
Q3 | $947K | Buy |
|
|||||
|
2018
Q2 | $1K | Sell |
|
|||||
|
2018
Q1 | $1.97M | Buy |
|
|||||
|
2017
Q4 | $8K | Sell |
|
|||||
|
2017
Q3 | $491K | Buy |
|
|||||
|
2017
Q2 | $7K | Buy |
|
|||||
|
2017
Q1 | $1K | Sell |
|
|||||
|
2016
Q4 | $13K | Buy |
|